Alpha Cognition Inc. Marketing and Advertising Expense
Alpha Cognition Inc. (ACOG) reported Marketing and Advertising Expense of $47.33 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2025-05-15
- Alpha Cognition Inc. marketing and advertising expense for the quarter ending 2025-03-31 was $47.33K, a 1477.24% increase year-over-year.
- Alpha Cognition Inc. marketing and advertising expense for the quarter ending 2024-12-31 was $85.66K, a 2220.18% increase year-over-year.
- Alpha Cognition Inc. marketing and advertising expense for the quarter ending 2024-09-30 was $6.62K, a 20.20% decline year-over-year.
- Alpha Cognition Inc. marketing and advertising expense for the quarter ending 2024-06-30 was $2.25K.
- Alpha Cognition Inc. marketing and advertising expense for fiscal 2024 was $97.53K, a 392.83% increase from fiscal 2023.
- Alpha Cognition Inc. marketing and advertising expense for fiscal 2023 was $19.79K.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $47.33K 10-Q · filed 2025-05-15 | $132.99K derived: sum of 2 quarters · filed 2025-05-15 | $139.62K derived: sum of 3 quarters · filed 2025-05-15 | $141.87K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $85.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $92.28K derived: sum of 2 quarters · filed 2025-03-31 | $94.53K derived: sum of 3 quarters · filed 2025-03-31 | $97.53K 10-K · filed 2025-03-31 |
| 2024-09-30 | $6.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $8.87K derived: sum of 2 quarters · filed 2024-11-14 | $11.87K 10-Q · filed 2024-11-14 | $15.57K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $2.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $5.25K 10-Q · filed 2024-08-12 | $8.94K derived: sum of 3 quarters · filed 2025-05-15 | $17.24K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-15 | $6.69K derived: sum of 2 quarters · filed 2025-05-15 | $14.99K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $3.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $11.99K derived: sum of 2 quarters · filed 2025-03-31 | $19.79K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $16.10K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $7.80K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |